Abstract
Stem Cell Collection with Daratumumab (DARA)-Based Regimens in Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) in the Griffin and Master Studies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have